We are live on
!
Find out more
MGB
Mass General Brigham Portfolio holdings
AUM
$361M
This Fund
S&P 500
This Quarter
Est. Return
-1.01%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$371M
AUM Growth
-$39.3M
(-9.6%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-9.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
3
Increased
1
Reduced
2
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XPeng
XPEV
|
+$1.52M |
| 2 |
Pinduoduo
PDD
|
+$859K |
| 3 |
Nurix Therapeutics
NRIX
|
+$491K |
| 4 |
Fulcrum Therapeutics
FULC
|
+$301K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$22.2M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.4M |
| 3 |
DOCU
DocuSign
DOCU
|
+$1.12M |
| 4 |
Snowflake
SNOW
|
+$1.09M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.91% |
| 2 | Consumer Discretionary | 1.45% |
| 3 | Healthcare | 0.25% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$904B
| $202M | 54.48% |
468,707
-50,054
| -10% | -$22.2M |
|
|
2
iShares Core US Aggregate Bond ETF
AGG
$138B
| $133M | 35.9% |
1,158,777
-106,626
| -8% | -$12.4M |
|
3
Coinbase
COIN
$39.3B
| $29.3M | 7.91% |
128,947
| – | – |
|
|
4
Pinduoduo
PDD
$127B
| $4.01M | 1.08% |
44,184
+8,834
| +25% | +$859K |
|
|
5
XPeng
XPEV
$11.2B
| $1.36M | 0.37% |
+38,370
| New | +$1.52M |
|
|
6
Nurix Therapeutics
NRIX
$2.76B
| $476K | 0.13% |
+15,904
| New | +$491K |
|
|
7
Fulcrum Therapeutics
FULC
$284M
| $447K | 0.12% |
+15,860
| New | +$301K |
|
|
8
CRISPR Therapeutics
CRSP
$5.22B
| – | – |
-6,464
| Closed | -$1.05M |
|
9
Dell
DELL
$313B
| – | – |
-7,969
| Closed | -$403K |
|
|
DOCU
10
DocuSign
DOCU
$11.1B
| – | – |
-4,003
| Closed | -$1.12M |
|
|
11
Snowflake
SNOW
$115B
| – | – |
-4,496
| Closed | -$1.09M |
|
|
JNCE
12
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-19,291
| Closed | -$131K |
|
Similar funds
PI
PWC
MCM
RA
A6
WTFG
5VM
SIAG
Mass General Brigham's Q3 2021 Portfolio in Review
As of Q3 2021, Mass General Brigham held 12 positions worth $371M, down 9.6% from $410M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mass General Brigham withdrew a net $35.2M in Q3 2021, closing 5 positions and reducing 2 holdings. Its most notable exit was DocuSign, an estimated $1.12M position sold in full.
By sector, the portfolio is most concentrated in Financials at 7.9% of assets, down from 8% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Mass General Brigham opened a new position in XPeng worth $1.36M.
- Mass General Brigham's largest Q3 2021 buy was XPeng: 38,370 shares worth $1.36M.
- Mass General Brigham added most to Pinduoduo in Q3 2021, an estimated $859K increase.
- Mass General Brigham's biggest Q3 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $22.2M.
- Mass General Brigham fully exited DocuSign in Q3 2021, selling an estimated $1.12M.
- Mass General Brigham's ten largest holdings make up 100% of its $371M portfolio in Q3 2021.
- Mass General Brigham opened 3 new positions and closed 5 in Q3 2021.
- Mass General Brigham's portfolio value fell 9.6% quarter-over-quarter to $371M.
Based on Mass General Brigham's 13F filing for Q3 2021, filed 8 Oct 2021.